StockComparison Logo
vs

ENGN vs BDTX

Comparison between enGene Holdings Inc (ENGN, Company) and Black Diamond Therapeutics Inc (BDTX, Company).

Both ENGN and BDTX are from the Healthcare sector.

ENGN vs BDTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ENGN
$107M
BDTX
$106M
Max Drawdown
Winner
ENGN
92.80%
BDTX
97.21%
Sharpe Ratio
Winner
ENGN
0.42
BDTX
0.04
5Y Beta
Winner
ENGN
0.86
BDTX
1.74
Industry
ENGN
Biotechnology
BDTX
Biotechnology
P/E Ratio
ENGN
-0.71
Winner
BDTX
-2.44
Forward P/E
ENGN
N/A
BDTX
8.33
PEG Ratio
ENGN
-0.01
BDTX
N/A
5Y EPS CAGR
ENGN
N/A
BDTX
-20.40%
Debt to Equity
ENGN
0.00%
BDTX
0.00%
Free Cash Flow Yield
ENGN
-96.83%
Winner
BDTX
-32.10%
P/S Ratio
ENGN
N/A
BDTX
2.11
P/B Ratio
Winner
ENGN
0.40
BDTX
1.04

ENGN vs BDTX - Historical Returns

Returns include dividend reinvestment.

1M
Winner
ENGN
+2.91%
BDTX
-37.45%
3M
ENGN
-75.52%
Winner
BDTX
-21.46%
6M
ENGN
-79.00%
Winner
BDTX
-35.09%
1Y
ENGN
-46.53%
Winner
BDTX
-28.03%
5Y(CAGR)
ENGN
N/A
BDTX
-33.04%
Max(CAGR)
ENGN
-60.36%
Winner
BDTX
-38.84%

ENGN vs BDTX - Annual Returns (2020 - 2026)

Returns include dividend reinvestment.

YearENGNBDTX
2026-80.00%-30.92%
2025+27.90%+13.55%
2024-27.40%-26.46%
2023-53.85%+52.72%
2022N/A-67.91%
2021N/A-83.47%
2020N/A-18.82%

ENGN vs BDTX Drawdown Comparison

The maximum drawdown for ENGN was -92.80%, occurring on May 12, 2026. This drawdown has not yet recovered.

The maximum drawdown for BDTX was -97.21%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current ENGN drawdown is -91.15%. The current BDTX drawdown is -96.16%.

RankENGNBDTX
#1-92.80%
Nov 1, 2023 - May 12, 2026
-97.21%
Jun 22, 2020 - Apr 8, 2025
#2N/A-53.95%
Jan 30, 2020 - Apr 24, 2020
#3N/A-19.84%
May 12, 2020 - Jun 22, 2020
#4N/A-17.80%
Apr 27, 2020 - May 8, 2020

Correlation

Correlation between ENGN and BDTX is 0.63 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.63
-101

Select Stocks to Compare